Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-21-052519

Chief Executive Officer bought 4,000 shares at $6.21 ($24,840)

From the SEC's structured data for this filing

Trades in this filing

Gros David-Alexandre C · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-08-17 Purchase : show line 1 in the form +4,000 $6.21 $24,840 7,000 D
Open-market purchases · 4,000 sh · avg $6.21 · $24,840
Loading xslF345X03/doc4.xml…